CUSIP: 05070R104
Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,960,466
-
Share change
-
+1,310,099
-
Total reported value
-
$271,964,916
-
Price per share
-
$17.04
-
Number of holders
-
57
-
Value change
-
+$22,292,094
-
Number of buys
-
26
-
Number of sells
-
17
Quarterly Holders Quick Answers
What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2017
-
Previous quarter:
Q4 2016
Recent filing periods for CUSIP 05070R104:
Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q1 2017
As of 31 Mar 2017,
AUDENTES THERAPEUTICS INC - COM (BOLD) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,960,466 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Versant Venture Management, LLC, DEERFIELD MANAGEMENT CO, BlackRock Inc., Redmile Group, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, LLC, Rock Springs Capital Management LP, and ALLIANCEBERNSTEIN L.P..
This page lists
57
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.